Health Care News – Read More The Food and Drug Administration’s (FDA) advisory committee on vaccines this week will consider whether to change the COVID-19 vaccine to target the XFG subvariant for the upcoming 2026-2027 respiratory viral season. The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet on Thursday to discuss whether COVID-19 vaccines should target the NB.1.8.1…
FDA advisers to weigh updated COVID vaccine targeting XFG subvariant
HootMD curates medical news from trusted publishers. Follow the links in this article to read the full story at the original source.
